Zantac was first linked to cancer on September 9, 2019, when Valisure pharmacy sent a citizen’s petition to the U.S. Food and Drug Administration (FDA). At this time, countless consumers were using Zantac to prevent and treat heartburn under the assumption that the drug was safe. Private testing, however, indicated “extremely high levels of N-Nitrososdimethylamine,” or NDMA, […]